Searched for
GLOBAL PHARMACEUTICAL MARKET TRENDS
US dollar heads into second half of 2026 as world’s top-performing major currencyThe US dollar is set to enter the second half of 2026 on a strong footing, supported by higher interest rates, resilient economic growth an...- GIFT Nifty tumbles over 150 points as global sell-off in AI stocks rattles sentimentGIFT Nifty signals a weak start for Indian markets after a sharp global sell-off led by declines in AI and semiconductor stocks across Asia...
- Zydus, Sunshine to set up $20 million pharma JV in Sri LankaIndian pharmaceutical giant Zydus Lifesciences has partnered with Sri Lanka's Sunshine Healthcare Lanka to establish a new manufacturing fa...
- Yen wobbles near 40-year low as dollar pauses for breathThe yen hovered near a 40-year low against the dollar as U.S. inflation data met expectations, leading traders to scale back bets on Federa...
- Dubai’s housing market cools after long red-hot five-year rallyDubai’s residential property market is cooling after a five-year rally as buyers become more price-sensitive, negotiate harder and shift to...
- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- Why is market rising today? Sensex soars 800 pts, Nifty above 24,250. 3 key factors powering D-St bullsIndian stock markets experienced a significant surge on Thursday, with both the Sensex and Nifty climbing over 1%. This bullish trend was f...
- Sensex jumps over 700 points, Nifty rises above 24,200 as oil prices cool below $73 per barrelOn Thursday, Indian stock markets experienced a remarkable surge, with both Sensex and Nifty seeing significant gains as oil prices fell be...
- Global Markets: MSCI keeps South Korea in emerging-market index, cites market accessibility hurdlesSouth Korea remains in the emerging-market category as MSCI cites persistent foreign exchange market accessibility issues. Despite ongoing ...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...
- Hormuz shipping activity shows signs of recovery; Indian refiners shine amid disruption: S&P GlobalShipping through the crucial Strait of Hormuz is showing signs of recovery, with daily transits increasing significantly, though still far ...
- India's services exports narrow gap with goods trade as overall trade grows 5.4% in Q4FY26: NITI AayogIndia's trade saw a healthy 5.4% growth in Q4 FY26, driven by robust services exports that significantly boosted the services trade surplus...
- India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- NFO Alert: Tata Mutual Fund announces launch of Tata Multi-sector Passive FoFTata Mutual Fund has launched the Tata Multi-sector Passive FoF, an open-ended scheme investing in passive equity funds across various sect...
- Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...
- Smaller cities power India’s corporate travel surgeCorporate travel in India is increasingly shifting towards smaller cities, with nearly 60% of bookings now originating from or heading to t...
- US probes Germany's drug pricing policies, opens door to tariffsThe US has launched a trade probe into Germany's pharmaceutical pricing, alleging it unfairly burdens American commerce and forces the US t...
- Falling crude, stronger rupee could boost earnings outlook for India: Deepak ShenoyIndian stocks are poised for a favorable period. Falling crude oil prices and a strengthening rupee offer support. Macroeconomic conditions...
Load More
